Thomas B, Beal M F. Parkinson's disease[J]. Human Molecular Genetics, 2007, 16(R2): R183-R194.
[2]
De Rijk M C, Launer L J, Berger K, et al. Prevalence of Parkinson's disease in Europe: A collaborative study of population-based cohorts. Neurologic diseases in the elderly research group[J]. Neurology, 2000, 54(11 S5): 21-23.
[3]
Polymeropoulos M H, Higgins J J, Golbe L I, et al. Mapping of a gene for Parkinson's disease to chromosome 4q21-q23[J]. Science, 1996, 274 (5290): 1197-1199.
Zarranz J J, Alegre J, Gomez-Esteban J C, et al. The new mutation, E46K, of α-synuclein causes Parkinson and Lewy body dementia[J]. Annals of Neurology, 2004, 55(2): 164-173.
[6]
Su Y, Duan J, Ying Z, et al. Increased vulnerability of parkin knock down PC12 cells to hydrogen peroxide toxicity: The role of salsolinol and NM-salsolinol[J]. Neuroscience, 2013, 233: 72-85.
[7]
Witt S N, Flower T R. α-Synuclein, oxidative stress and apoptosis from the perspective of a yeast model of Parkinson's disease[J]. FEMS Yeast Research, 2006, 6(8): 1107-1116.
[8]
Garcia-Reitbock P, Anichtchik O, Dalley J W, et al. Endogenous α- synuclein influences the number of dopaminergic neurons in mouse substantia nigra[J]. Experimental Neurology, 2013, 248: 541-545.
[9]
George S, Rey N L, Reichenbach N, et al. α-Synuclein: the long distance runner[J]. Brain Pathology, 2013, 23(3): 350-357.
[10]
Bendor J T, Logan T P, Edwards R H. The Function of α-Synuclein[J]. Neuron, 2013, 79(6): 1044-1066.
[11]
Lotharius J, Brundin P. Pathogenesis of Parkinson's disease: Dopamine, vesicles and α-synuclein[J]. Nature Reviews Neuroscience, 2002, 3(12): 932-942.
[12]
Lane E, Dunnett S. Animal models of Parkinson's disease and L-dopa induced dyskinesia: How close are we to the clinic?[J]. Psychopharma- cology, 2008, 199(3): 303-312.
[13]
Blesa J, Phani S, Jackson-Lewis V, et al. Classic and new animal models of Parkinson's disease[J/OL]. Journal of Biomedicine & Bio- technology,2012,[2013-12-09]. http://dx.doi.org/10.1155/2012/845618.
[14]
Krüger R, Kuhn W, Müller T, et al. AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease[J]. Nature Genetics, 1998, 18(2): 106-108.
[15]
Chinta S J, Lieu C A, Demaria M, et al. Environmental stress, ageing and glial cell senescence: A novel mechanistic link to Parkinson's disease?[J]. Journal of Internal Medicine, 2013, 273(5): 429-436.
[16]
Singleton A B, Farrer M J, Bonifati V. The genetics of Parkinson's disease: Progress and therapeutic implications[J]. Movement Disorders, 2013, 28(1): 14-23.
[17]
Kang J H. Salsolinol, a catechol neurotoxin, induces oxidative modifi- cation of cytochrome c[J]. BMB Reports, 2013, 46(2): 119-123.
